Monsanto Company (MON) 101.80 $MON Look for Shares of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Monsanto Company (MON) 101.80 $MON

Look for Shares of Monsanto to Potentially Pullback after Yesterday's 1.09% Rise
Comtex SmarTrend(R) - Fri Jul 08, 2:23PM CDT
Monsanto (NYSE:MON) traded in a range yesterday that spanned from a low of $100.80 to a high of $101.76. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $101.48 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MON: 101.80 (-0.53)

Dow 30 Stock Roundup: Chevron, Exxon Mobil to Invest in Kazakh Oil Field, Disney to Buy Stake in MLB Advanced Media
Swarup Gupta - Zacks Investment Research - Fri Jul 08, 10:05AM CDT
The Dow inched marginally upward during a holiday shortened week.
MON: 101.80 (-0.53), JPM: 62.99 (-0.21), IBM: 157.97 (+0.93), MRK: 59.58 (-0.02), XOM: 94.42 (-0.53), DIS: 100.03 (-0.17), CVX: 106.39 (-0.39), MSFT: 53.66 (+0.45), CSCO: 29.77 (+0.16)

Monsanto and DuPont Sign Multi-Year Herbicide Supply Deal
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:07AM CDT
Monsanto Company and DuPont have inked a multi-year supply deal in Canada and the United States for the weed destroyer, dicamba.
BG: 60.21 (-0.25), MON: 101.80 (-0.53), DD: 66.11 (+0.17), AKS: 5.30 (-0.13)


Asian markets mostly down on oil concerns
By TERESA CEROJANO - AP - Thu Jul 07, 10:18PM CDT
MANILA, Philippines (AP) — Asian shares were mostly down Friday, with investors cautious due to the plunge in oil prices overnight, concerns that a correction in commodity prices is underway and Friday night's scheduled release of U.S. inflation data that carries the risk of market volatility.
XEL: 43.92 (+0.42), MON: 101.80 (-0.53), DUK: 84.82 (+0.38), COST: 166.84 (+0.56), WDC: 52.17 (+0.33), AET: 117.76 (+2.26), SNDK: 76.18 (-0.39), HUM: 155.69 (+0.98), PEP: 109.62 (+0.83)

Monsanto and DuPont Sign Dicamba Supply Agreement
BusinessWire - Thu Jul 07, 9:00AM CDT
Monsanto Company (NYSE: MON) and DuPont (NYSE: DD) today announced a multi-year dicamba supply agreement for the U.S. and Canada. Terms of the agreement were not disclosed.
MON: 101.80 (-0.53), DD: 66.11 (+0.17)

The Zacks Analyst Blog Highlights: Microsoft, Monsanto, QUALCOMM and Citrix Systems
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:30AM CDT
The Zacks Analyst Blog Highlights: Microsoft, Monsanto, QUALCOMM and Citrix Systems
MON: 101.80 (-0.53), QCOM: 54.84 (+0.22), MSFT: 53.66 (+0.45), CTXS: 84.14 (+0.17)

New Strong Sell Stocks for July 7th
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 7:16AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
MON: 101.80 (-0.53), CNS: 42.63 (+0.63), CPA: 64.44 (+1.66), DST: 122.01 (-0.18), BGCP: 8.81 (+0.05)

Microsoft/Monsanto to Invest in Brazilian Agrotech Startups
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 9:47AM CDT
Microsoft Corporation (MSFT) has announced a partnership with Monsanto Company (MON) to invest in agricultural technology startups in Brazil.
MON: 101.80 (-0.53), QCOM: 54.84 (+0.22), MSFT: 53.66 (+0.45), CTXS: 84.14 (+0.17)

Top 6 Research Reports for June 30, 2016
Sheraz Mian - Zacks Investment Research - Thu Jun 30, 1:36PM CDT
Top 6 Research Reports for June 30, 2016
GS: 157.44 (+0.52), MCK: 196.97 (+1.50), MON: 101.80 (-0.53), NKE: 57.98 (-0.08), GOOGL: 731.86 (-0.65), CAT: 79.47 (-0.33)

Monsanto (MON) Q3 Earnings and Revenues Miss, Down Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 10:01AM CDT
Monsanto Company (MON) reported weak third-quarter fiscal 2016 (ended May 31, 2016) results.
BTG: 3.06 (+0.12), MON: 101.80 (-0.53), AG: 16.97 (+1.56), ALB: 85.40 (+0.18)

Watch for Shares of Monsanto (MON) to Approach Resistance at $103.13
Comtex SmarTrend(R) - Wed Jun 29, 9:09AM CDT
Monsanto (NYSE:MON) has opened bullishly above the pivot of $100.97 today and has reached the first level of resistance at $102.11. Analysts will be watching for a cross of the next upside pivot targets of $103.13 and $105.28.
MON: 101.80 (-0.53)

Monsanto (MON) Misses Q3 Earnings and Revenues
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:32AM CDT
Monsanto Company (MON) has carved a name for itself in the global agricultural chemicals??? industry.
MON: 101.80 (-0.53)

Monsanto Reports Third Quarter Financial Results; Company Remains Innovation Partner of Choice, Securing Several Recent Technology and Operational Agreements
BusinessWire - Wed Jun 29, 7:00AM CDT
--Full-year FY16 as-reported EPS guidance adjusted to $3.36 to $4.14 to reflect Argentine-related tax matters partially offset by a favorable change in the expected amount and timing of restructuring expense; anticipate being at low ends of as-reported range and ongoing EPS range of $4.40 to $5.10 given increased headwinds in Q3
MON: 101.80 (-0.53)

DuPont, Monsanto Ink Licensing Deal for Soybean Technology
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 3:28PM CDT
DuPont (DD) and Monsanto (MON) have signed a licensing agreement for one of Monsanto's next-generation soybean technologies that will offer an additional option for farmers.
MON: 101.80 (-0.53), IOSP: 49.11 (+0.24), DD: 66.11 (+0.17), IPHS: 42.20 (-0.06)

Will Monsanto Engineer Growth this Quarter?
ESTMZ - Tue Jun 28, 3:00PM CDT
Monsanto Co. ( MON ) Materials - Chemicals | Reports June 29, Before Market Opens Key Takeaways The Estimize consensus is looking for earnings per share of $2.44 on $4.42 billion in revenue this quarter, 3 cents higher than Wall Street on the...
SPY: 214.86 (-0.09), MON: 101.80 (-0.53)

Monsanto (MON) on a Roll: Signs Back-to-Back Agreements
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 10:08AM CDT
Renowned Agricultural Chemicals firm Monsanto Company (MON) has entered into new agreements with DuPont and Sumitomo Chemical Company, Ltd.
BTG: 3.06 (+0.12), MON: 101.80 (-0.53), AG: 16.97 (+1.56), ALB: 85.40 (+0.18)

Monsanto and Nomad Bioscience Announce Collaboration on Gene-Editing Research for Next-Generation Agriculture Solutions
BusinessWire - Tue Jun 28, 9:30AM CDT
Monsanto Company (NYSE: MON) and Nomad Bioscience GmbH have announced a licensing agreement whereby Monsanto has obtained rights to apply Nomad's proprietary technology to its genome-editing projects aimed at enhancement of agricultural crops. The licensed technology enables more efficient development of edited traits and may be applied across a broad range of genome-editing technologies and project types. Nomad's novel approach holds the promise to accelerate the development of improved agricultural products via genome editing.
MON: 101.80 (-0.53)

5 Stocks to Watch this Week 6/27 - NKE, CCL, MON, MU, DRI
ESTMZ - Mon Jun 27, 4:50PM CDT
Tuesday, June 28 Wednesday, June 29 Thursday, June 30 Nike ( NKE ) Consumer Discretionary - Textiles, Apparel & Luxury Goods | Reports June 28, after the close. The Estimize consensus is calling for earnings per...
MU: 13.25 (+0.02), SPY: 214.86 (-0.09), MON: 101.80 (-0.53), CCL: 46.76 (+0.05), NKE: 57.98 (-0.08), DRI: 62.77 (-0.03)

Monsanto and Sumitomo Chemical Enter New Global Crop Protection Collaboration for Next Generation PPO Technologies
BusinessWire - Mon Jun 27, 3:30PM CDT
Monsanto Company (NYSE: MON) and Sumitomo Chemical Company, Ltd. today announced a new global agreement that will focus on developing and delivering next-generation weed control solutions to further help growers manage tough-to-control weeds.
MON: 101.80 (-0.53)

After Yesterday's Decline of 3.78%, Monsanto Offers Investors Better Value
Comtex SmarTrend(R) - Fri Jun 24, 3:24PM CDT
Monsanto (NYSE:MON) traded in a range yesterday that spanned from a low of $104.57 to a high of $106.61. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $106.72 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MON: 101.80 (-0.53)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nuvini Group Limited Achieves Remarkable Growth in 2024

Updated Category News Views 242

Outstanding Financial Performance Delivered by Nuvini Group NEW YORK — Nuvini Group Limited (Nasdaq: NVNI) has released its financial results for the first half of 2024, demonstrating impressive growth across various metrics. The company continues to set the bar high in the realm of private SaaS B2B acquisitions in Latin America. Growth Metrics Highlight Success The...

Continue Reading
MarketFully Expands Reach with Social Element Acquisition

Updated Category News Views 168

MarketFully Enhances Capabilities with New Acquisition Markfully, the leader in InContent Marketing, has broadened its horizons through the acquisition of a prominent global social media agency, Social Element. This strategic move is set to amplify MarketFully's capacity for delivering multilingual content marketing solutions, particularly across social media platforms....

Continue Reading
Lone Star Family Health Center Partners with athenahealth to Enhance Patient Care

Updated Category News Views 717

Lone Star Family Health Center Partners with athenahealth for Enhanced Care Lone Star Family Health Center (LSFHC), a notable health service provider, has made a major decision to transition to athenaOne, a cutting-edge suite of medical software. This strategic move aims to elevate patient care experiences and health outcomes substantially. athenahealth, well-known for...

Continue Reading
Promising Long-Term Results for Zeposia in Multiple Sclerosis

Updated Category News Views 123

Zeposia (ozanimod): A Breakthrough in Multiple Sclerosis Treatment Bristol Myers Squibb has recently shared compelling long-term findings from the Phase 3 DAYBREAK trial on Zeposia (ozanimod). This promising oral treatment has proven effective in managing relapsing forms of multiple sclerosis (MS). The results underscore Zeposia's sustained effectiveness and safety, which...

Continue Reading
Encompass Health Expands Its Rehabilitation Services in Florida

Updated Category News Views 268

Encompass Health Opens New Rehabilitation Hospital Encompass Health has recently made a significant impact in the healthcare landscape by launching a new facility. The Encompass Health Rehabilitation Hospital of St. Petersburg is now officially open to patients, marking the company's 25th location in Florida. Quality Care for Patients This facility is aimed at improving...

Continue Reading